Fentanyl Transdermal Patches bulk supplier for pharma manufacturers

Fentanyl Transdermal Patches Suppliers & Bulk Manufacturers

Available Forms: Transdermal Patches

Available Strengths: 12, 25, 50, 75, 100 mcg/hr

Reference Brands: Durogesic(US & EU)

Category: Analgesic

Fentanyl Transdermal Patches is available in Transdermal Patches and strengths such as 12, 25, 50, 75, 100 mcg/hr. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fentanyl Transdermal Patches is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Fentanyl Transdermal Patches can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Fentanyl transdermal patches are approved in the EU and US for managing severe, chronic pain in opioid-tolerant patients. In the EU, brands like Durogesic are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. Due to high abuse potential, strict regulations and proper guidelines are enforced. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for fentanyl patches, ensuring adherence to European and American standards for safe, effective pain management.

Frequently Asked Questions

Yes, Fentanyl Transdermal Patches is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Fentanyl Transdermal Patches is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Alfentanil

Strength:
500 mcg/mL

Form: Injection

Reference Brands: Alfenta (USA), Rapifen (EU)

View Details
Hydromorphone Tablet

Strength:
2mg, 4mg, 8mg / 1 mg/mL, 2 mg/mL, 4 mg/mL

Form: Tablets/ capsules/ Injectable / Oral Solution

Reference Brands: Dilaudid (USA), Exalgo, Palladone(EU/UK)

View Details
Nabumetone Tablet

Strength:
500 mg, 750 mg, 1000 mg

Form: Tablets

Reference Brands: Relafen (USA/EU), Relifex (EU/UK), Gambaran

View Details
Paracetamol (Acetaminophen) Injection

Strength:
1000 mg/100 mL (10 mg/mL)

Form: Injectable solution

Reference Brands: Ofirmev

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.